Arnold Palmer Cancer Center Medical Oncology Norwin
N Huntingdon, Pennsylvania, United States
About Arnold Palmer Cancer Center Medical Oncology Norwin
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Arnold Palmer Cancer Center Medical Oncology Norwin
During the past decade, Arnold Palmer Cancer Center Medical Oncology Norwin conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
2015-07-13
2023-10-02
Active, not recruiting
300
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Arnold Palmer Cancer Center Medical Oncology Norwin"
#1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Arnold Palmer Cancer Center Medical Oncology Norwin
According to Clinical.Site data, the most researched conditions in "Arnold Palmer Cancer Center Medical Oncology Norwin" are
"Lung Non-Squamous Non-Small Cell Carcinoma" (3 trials), "Stage IIIB Lung Cancer AJCC v8" (3 trials), "Stage IV Lung Cancer AJCC v8" (3 trials), "Bladder Adenocarcinoma" (2 trials) and "Stage IIIA Lung Cancer AJCC v8" (2 trials). Many other conditions were trialed in "Arnold Palmer Cancer Center Medical Oncology Norwin" in a lesser frequency.
Clinical Trials Intervention Types at Arnold Palmer Cancer Center Medical Oncology Norwin
Most popular intervention types in "Arnold Palmer Cancer Center Medical Oncology Norwin" are "Drug" (16 trials), "Biological" (10 trials), "Procedure" (10 trials), "Other" (7 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.
The name of intervention was led by "Computed Tomography" (8 trials), "Carboplatin" (6 trials), "Magnetic Resonance Imaging" (6 trials), "Biospecimen Collection" (5 trials) and "Nivolumab" (5 trials). Other intervention names were less common.
Clinical Trials Genders at Arnold Palmer Cancer Center Medical Oncology Norwin
The vast majority of trials in "Arnold Palmer Cancer Center Medical Oncology Norwin" are
17 trials for "All" genders.
Clinical Trials Status at Arnold Palmer Cancer Center Medical Oncology Norwin
Currently, there are NaN active trials in "Arnold Palmer Cancer Center Medical Oncology Norwin".
undefined are not yet recruiting,
11 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Arnold Palmer Cancer Center Medical Oncology Norwin,
1 suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Arnold Palmer Cancer Center Medical Oncology Norwin, 0 "Phase 1"
clinical trials were conducted, 11 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".